Retatrutide is not just another GLP-1 peptide
GCA interacts with the Prohibitin-2 (PHB2) receptor on adipocytes, activating the PAK1-NF-B signaling pathway and inducing innate and adaptive immune responses
So putting collagen-fragment-identical peptides on the skin might trick it into thinking that new collagen is needed
[CrossRef] [Google Scholar] Untargeted Lipidomic Profiling of Dry Blood Spots Using SFC-HRMS
Danuglipron: the discontinued competitor Pfizer was developing danuglipron, another small-molecule oral GLP-1 agonist
This product is presented strictly for research use only and is not intended for human use, animal use, diagnosis, treatment, prevention, consumption, cosmetic use, skin use, anti-aging use, performance use, recovery use, or personal application